IHI. Hosokawa

I. Hosokawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


I. Hosokawa has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • H. Nakae

    Department of Conservative Dentistry, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Tokushima, Japan

    2 shared publications
  • K. Ozaki

    The University of Tokushima, Faculty of Dentistry, School of Oral Health and Welfare, Oral Health Care Promotion, Tokushima, Tokushima, Japan

    2 shared publications
  • T. Matsuo

    Department of Conservative Dentistry, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Tokushima, Japan

    2 shared publications
  • H. Yumoto

    Department of Conservative Dentistry, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Tokushima, Japan

    1 shared publication
  • Y. Hosokawa

    Department of Conservative Dentistry, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan

    1 shared publication
  • Yoshitaka Hosokawa

    Department of Conservative Dentistry and Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Tokushima, Japan

    1 shared publication

Latest Publications

  • Proinflammatory effects of muramyldipeptide on human gingival fibroblasts

    by I. Hosokawa, Y. Hosokawa, K. Ozaki, H. Yumoto, H. Nakae, T. Matsuo

    Hosokawa I, Hosokawa Y, Ozaki K, Yumoto H, Nakae H, Matsuo T. Proinflammatory effects of muramyldipeptide on human gingival fibroblasts. J Periodont Res 2010; 45: 193–199. © 2010 The Authors. Journal compilation © 2010 Blackwell Munksgaard Background and Objective: Because human gingival fibroblasts (HGFs) are the predominant cells in periodontal tissues, we hypothesized that HGFs are contributed to receptors for components of bacteria. In this study, we focused on expression and function of nucleotide binding oligomerization domain 2 (NOD2) in HGFs, which is a mammalian cytosolic pathogen recognition molecule. Material and Methods: Expression of NOD2 in HGFs was examined by reverse transcriptase‐polymerase chain reaction (RT‐PCR) and flow cytometry. Production of interleukin (IL)‐6, IL‐8, cc chemokine ligand2, cxc chemokine ligand10 (CXCL10) and CXCL11 from HGFs was examined by enzyme‐linked immunosorbent assay (ELISA). We used RT‐PCR and immunohistochemistry to detect the NOD2 expression in human gingival tissues. Results: We found clear NOD2 expression in HGFs. Upon stimulation with NOD2 agonist, muramyldipeptide (MDP), production of proinflammatory cytokines was enhanced. Moreover, MDP‐induced production of proinflammatory cytokines was inhibited in a different manner by mitogen‐activated protein kinase inhibitors and phosphatidylinositol 3‐kinase inhibitor. Furthermore, MDP enhanced CXCL10 and CXCL11 productions by tumor necrosis factor‐α (TNF‐α)‐ or interferon‐γ (IFN‐γ)‐stimulated HGFs, although MDP alone did not induce these chemokines. TNF‐α and IFN‐γ increased NOD2 expression in HGFs. In addition, we detected NOD2 expression in mononuclear cells and HGFs in periodontally diseased tissues. Conclusion: These findings indicate that MDP which induces production of cytokines and chemokines from HGFs is related to the pathogenesis of periodontal disease.


  • Cytokines differentially regulate CXCL10 production by interferon‐γ‐stimulated or tumor necrosis factor‐α‐stimulated human gingival fibroblasts

    by Y. Hosokawa, I. Hosokawa, K. Ozaki, H. Nakae, T. Matsuo

    Background and Objective:  CXC chemokine 10 (CXCL10) activates CXC chemokine receptor 3 (CXCR3) and attracts activated T‐helper 1 cells. In this study we examined the effects of cytokines on CXCL10 production by human gingival fibroblasts.Material and Methods:  Human gingival fibroblasts were exposed to pro‐inflammatory cytokines (interleukin‐1β, tumor necrosis factor‐α), a T‐helper 1 cytokine (interferon‐γ), T‐helper 2 cytokines (interleukin‐4, interleukin‐13), T‐helper 17 cytokines (interleukin‐17A, interleukin‐22) and regulatory T‐cell cytokines (interleukin‐10, transforming growth factor‐β1) for 24 h. CXCL10 production by human gingival fibroblasts was examined by enzyme‐linked immunosorbent assay.Results:  Human gingival fibroblasts produced CXCL10 protein upon stimulation with interleukin‐1β, tumor necrosis factor‐α and interferon‐γ. Treatment of human gingival fibroblasts with interferon‐γ in combination with tumor necrosis factor‐α or interleukin‐1β resulted in a synergistic production of CXCL10. However, interleukin‐4 and interleukin‐13 inhibited CXCL10 production by interferon‐γ‐stimulated or tumor necrosis factor‐α‐stimulated‐human gingival fibroblasts. On the other hand, interleukin‐17A and interleukin‐22 enhanced CXCL10 production by human gingival fibroblasts treated with interferon‐γ and inhibited CXCL10 production by tumor necrosis factor‐α‐stimulated human gingival fibroblasts. Furthermore, the anti‐inflammatory cytokine, interleukin‐10, inhibited CXCL10 production by both interferon‐γ‐ and tumor necrosis factor‐α‐stimulated human gingival fibroblasts, but transforming growth factor‐β1 enhanced interferon‐γ‐mediated CXCL10 production by human gingival fibroblasts.Conclusion:  These results mean that the balance of cytokines in periodontally diseased tissue may be essential for the control of CXCL10 production by human gingival fibroblasts, and the production of CXCL10 might be important for the regulation of T‐helper 1 cell infiltration in periodontally diseased tissue.